Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 7
1988 18
1989 24
1990 20
1991 17
1992 19
1993 26
1994 25
1995 29
1996 32
1997 30
1998 26
1999 33
2000 24
2001 34
2002 36
2003 30
2004 38
2005 53
2006 39
2007 54
2008 67
2009 62
2010 70
2011 90
2012 81
2013 118
2014 194
2015 232
2016 214
2017 214
2018 236
2019 236
2020 261
2021 257
2022 267
2023 232
2024 91

Text availability

Article attribute

Article type

Publication date

Search Results

3,022 results

Results by year

Filters applied: . Clear all
Page 1
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society.
Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B, Deharo JC, Deneke T, Di Biase L, Enriquez-Sarano M, Donal E, Imai K, Lim HS, Marsan NA, Turagam MK, Peichl P, Po SS, Haugaa KH, Shah D, de Riva Silva M, Bertrand P, Saba M, Dweck M, Townsend SN, Ngarmukos T, Fenelon G, Santangeli P, Sade LE, Corrado D, Lambiase P, Sanders P, Delacrétaz E, Jahangir A, Kaufman ES, Saggu DK, Pierard L, Delgado V, Lancellotti P. Sabbag A, et al. Europace. 2022 Dec 9;24(12):1981-2003. doi: 10.1093/europace/euac125. Europace. 2022. PMID: 35951656 Free article. No abstract available.
Global epidemiology of valvular heart disease.
Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zühlke L, Prendergast BD. Coffey S, et al. Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25. Nat Rev Cardiol. 2021. PMID: 34172950 Review.
Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life and longevity. ...By contrast, the prevalence of calcific aortic stenosis and degenerative mitral valve disease is 9 and 24 million people, respectively. …
Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life and longevity. ...By contras …
Management of Patients With Aortic Valve Stenosis.
Kanwar A, Thaden JJ, Nkomo VT. Kanwar A, et al. Mayo Clin Proc. 2018 Apr;93(4):488-508. doi: 10.1016/j.mayocp.2018.01.020. Mayo Clin Proc. 2018. PMID: 29622096 Review.
With increased life expectancy and aging of the population, aortic stenosis is now one of the most common valvular heart diseases. Early recognition and management of aortic stenosis are of paramount importance because untreated symptomatic severe disease is …
With increased life expectancy and aging of the population, aortic stenosis is now one of the most common valvular heart diseases …
Mitral regurgitation.
Enriquez-Sarano M, Akins CW, Vahanian A. Enriquez-Sarano M, et al. Lancet. 2009 Apr 18;373(9672):1382-94. doi: 10.1016/S0140-6736(09)60692-9. Epub 2009 Apr 6. Lancet. 2009. PMID: 19356795 Review.
Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of coronary disease) in developed countries, or rheumatic (in developing countries). ...Su …
Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolap …
Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches.
Eleid MF, Nkomo VT, Pislaru SV, Gersh BJ. Eleid MF, et al. Annu Rev Med. 2023 Jan 27;74:155-170. doi: 10.1146/annurev-med-042921-122533. Epub 2022 Nov 18. Annu Rev Med. 2023. PMID: 36400067 Free article. Review.
This review discusses recent advancements in the field of valvular heart disease. Topics covered include recognition of the impact of atrial fibrillation on development and assessment of valvular disease, strategies for global prevention of rheumatic heart …
This review discusses recent advancements in the field of valvular heart disease. Topics covered include recognition of the im …
Burden of valvular heart diseases: a population-based study.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Nkomo VT, et al. Lancet. 2006 Sep 16;368(9540):1005-11. doi: 10.1016/S0140-6736(06)69208-8. Lancet. 2006. PMID: 16980116
BACKGROUND: Valvular heart diseases are not usually regarded as a major public-health problem. ...FINDINGS: In the general population group, moderate or severe valve disease was identified in 615 adults. There was no difference in the frequency of such …
BACKGROUND: Valvular heart diseases are not usually regarded as a major public-health problem. ...FINDINGS: In the general pop …
Aortic Stenosis: Diagnosis and Treatment.
Grimard BH, Safford RE, Burns EL. Grimard BH, et al. Am Fam Physician. 2016 Mar 1;93(5):371-8. Am Fam Physician. 2016. PMID: 26926974 Free article. Review.
During the asymptomatic latent period, left ventricular hypertrophy and atrial augmentation of preload compensate for the increase in afterload caused by aortic stenosis. As the disease worsens, these compensatory mechanisms become inadequate, leading to symptoms of hea …
During the asymptomatic latent period, left ventricular hypertrophy and atrial augmentation of preload compensate for the increase in afterl …
Valvular heart disease: shifting the focus to the myocardium.
Ajmone Marsan N, Delgado V, Shah DJ, Pellikka P, Bax JJ, Treibel T, Cavalcante JL. Ajmone Marsan N, et al. Eur Heart J. 2023 Jan 1;44(1):28-40. doi: 10.1093/eurheartj/ehac504. Eur Heart J. 2023. PMID: 36167923 Free PMC article. Review.
Adverse cardiac remodelling is the main determinant of patient prognosis in degenerative valvular heart disease (VHD). However, to give an indication for valvular intervention, current guidelines include parameters of cardiac chamber dilatation or function which are …
Adverse cardiac remodelling is the main determinant of patient prognosis in degenerative valvular heart disease (VHD). However …
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes.
Michelena HI, Della Corte A, Evangelista A, Maleszewski JJ, Edwards WD, Roman MJ, Devereux RB, Fernández B, Asch FM, Barker AJ, Sierra-Galan LM, De Kerchove L, Fernandes SM, Fedak PWM, Girdauskas E, Delgado V, Abbara S, Lansac E, Prakash SK, Bissell MM, Popescu BA, Hope MD, Sitges M, Thourani VH, Pibarot P, Chandrasekaran K, Lancellotti P, Borger MA, Forrest JK, Webb J, Milewicz DM, Makkar R, Leon MB, Sanders SP, Markl M, Ferrari VA, Roberts WC, Song JK, Blanke P, White CS, Siu S, Svensson LG, Braverman AC, Bavaria J, Sundt TM, El Khoury G, De Paulis R, Enriquez-Sarano M, Bax JJ, Otto CM, Schäfers HJ; Endorsed by the Heart Valve Society (HVS), European Association of Cardiovascular Imaging (EACVI), Society of Thoracic Surgeons (STS), American Association for Thoracic Surgery (AATS), Society for Cardiovascular Magnetic Resonance (SCMR), Society of Cardiovascular Computed Tomography (SCCT), North American Society for Cardiovascular Imaging (NASCI) and the International Bicuspid Aortic Valve Consortium (BAVCon). Michelena HI, et al. Eur J Cardiothorac Surg. 2021 Sep 11;60(3):448-476. doi: 10.1093/ejcts/ezab038. Eur J Cardiothorac Surg. 2021. PMID: 34293102 Free article.
This International Consensus Classification and Nomenclature for the congenital bicuspid aortic valve condition recognizes 3 types of bicuspid valves: 1. The fused type (right-left cusp fusion, right-non-coronary cusp fusion and left-non-coronary cusp fusion phenotypes); 2 …
This International Consensus Classification and Nomenclature for the congenital bicuspid aortic valve condition recognizes 3 types of …
Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications.
Prihadi EA, Delgado V, Leon MB, Enriquez-Sarano M, Topilsky Y, Bax JJ. Prihadi EA, et al. JACC Cardiovasc Imaging. 2019 Mar;12(3):491-499. doi: 10.1016/j.jcmg.2018.09.027. JACC Cardiovasc Imaging. 2019. PMID: 30846123 Free article. Review.
Primary TR is caused by an anatomical abnormality of the tricuspid valve apparatus. Secondary TR is caused by dilation of the tricuspid valve annulus, related to right ventricular (RV), or right atrial remodeling and increased RV pressures (often secondary to left-s …
Primary TR is caused by an anatomical abnormality of the tricuspid valve apparatus. Secondary TR is caused by dilation of the tricusp …
3,022 results